Steady Expansion Forecast for Synthetic Hormones Market, Projected to Reach $7.98 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Synthetic Hormones Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for synthetic hormones has seen impressive growth in the past few years. It is projected to expand from $6.38 billion in 2024 to $6.71 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%. Factors such as animal growth promotion, performance enhancement, environmental impact, fertility treatments, and management of menopausal symptoms have contributed to the growth in the historical period.

Synthetic Hormones Market Size Forecast: What's the Projected Valuation by 2029?
In the forthcoming years, the synthetic hormones market is predicted to enjoy stable growth, expanding to a size of "$7.98 billion in 2029" with a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this expected growth during the forecast period include the enlargement of the transgender healthcare market, increased healthcare spending and insurance coverage, regulatory green lights, and broader uses of synthetic hormones. Significant trends for the forecasting period consist of the emergence of plant-based hormone therapy, the incorporation of hormone therapy into anti-aging treatments, advancements in drug delivery technology, and a shift towards hormone-free birth control.

View the full report here:
https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

What Are the Drivers Transforming the Synthetic Hormones Market?
The synthetic hormones market is predicted to see growth propelled by a rise in hormonal imbalances. Hormonal imbalances, characterized by either an excess or deficiency of a specific hormone in the bloodstream, may occur as a result of stress, aging, lifestyle choices, or certain medical conditions and disrupt the normal production and regulation of hormones. Synthetic hormones are utilized to either replace or supplement natural hormones in cases of hormonal imbalance, aiding in the management of bodily functions and relieving symptoms linked to hormonal excesses or deficiencies. For example, data from the NHS Business Services Authority, a non-departmental public entity in the UK, indicated that approximately 7.80 million hormone replacement therapy (HRT) items were dispensed in England in 2022, a 35.0% rise from the previous year. As a result, the escalating incidence of hormonal imbalances is fuelling the expansion of the synthetic hormones market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

What Trends Will Shape the Synthetic Hormones Market Through 2029 and Beyond?
Leading firms in the synthetic hormone industry are striving to create novel products like the recombinant human growth hormone in order to boost their market profitability. This synthetic hormone is utilized for treating growth hormone deficiencies in both children and adults and some specific medical conditions linked with this deficiency. For instance, Pfizer Inc., an American pharmaceutical giant, and OPKO Health Inc., a US-based medical test and drug company, have secured marketing approval for their once-weekly NGENLA (somatrogon) injections within the European Union in February 2022. These injections target pediatric growth hormone deficiency and are intended for children and teenagers aged three and above. The introduction of this long-acting injection offers a new option for patients dealing with growth disruptions due to inadequate growth hormone secretion. NGENLA, injected subcutaneously, has a more prolonged body-staying time compared to daily growth hormone injections, thus necessitating only a weekly use.

Which Segments in the Synthetic Hormones Market Offer the Most Profit Potential?
The synthetic hormones market covered in this report is segmented -

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types
2) By Route of Administration: Oral, Nasal, Topical, Intravenous
3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications
4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins
2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin
3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin
4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Which Firms Dominate the Synthetic Hormones Market by Market Share and Revenue in 2025?
Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Which Regions Offer the Highest Growth Potential in the Synthetic Hormones Market?
North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.